Active Ingredient(s): Istradefylline
FDA Approved: * August 27, 2019
Pharm Company: * KYOWA KIRIN
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nourianz Overview

Istradefylline, sold under the brand name Nourianz, is a medication used as an add-on treatment to levodopa/carbidopa in adults with Parkinson's disease (PD) experiencing "off" episodes.[2][3][4] Istradefylline reduces "off" periods resulting from long-term treatment with the antiparkinson drug levodopa.[2] An "off" episode is a time when a patient's medications are not working well, causing an increase in PD symptoms, such as tr...

Read more Nourianz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nourianz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 20mg, 40mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nourianz: (2 results)

Sorted by National Drug Code
  • 42747-602 Nourianz 20 mg Oral Tablet, Film Coated by Kyowa Kirin, Inc.
  • 42747-604 Nourianz 40 mg Oral Tablet, Film Coated by Kyowa Kirin, Inc.

Other drugs which contain Istradefylline or a similar ingredient: (1 result)